Back
Primoris Services Vs. Apellis Pharmaceuticals Industry Stock Comparison
Buy
82
PRIM
Primoris Services
Last Price:
59.08
Seasonality Move:
8.08%
Sell
19
APLS
Apellis Pharmaceuticals
Last Price:
32.49
Seasonality Move:
18.8%
Buy
82
Primoris Services (PRIM)
is a Buy
Is Primoris Services a Buy, Sell or Hold?
- The current Primoris Services [PRIM] share price is $59.12. The Score for PRIM is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- PRIM is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Sell
19
Apellis Pharmaceuticals (APLS)
is a Sell
Is Apellis Pharmaceuticals a Buy, Sell or Hold?
- The current Apellis Pharmaceuticals [APLS] share price is $32.50. The Score for APLS is 19, which is 62% below its historic median score of 50, and infers higher risk than normal.
- APLS is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
PRIM Stock Price Chart
What is Primoris Services's stock price today?
-
The Primoris Services share price today is $59.12
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRIM is experiencing selling pressure, which indicates risk of future bearish movement.
APLS Stock Price Chart
What is Apellis Pharmaceuticals's stock price today?
-
The Apellis Pharmaceuticals share price today is $32.50
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and APLS is experiencing slight selling pressure.
PRIM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.22 | Buy |
| Relative Strength Index (14 RSI): | 66.9 | Buy |
| Chaikin Money Flow: | -474845 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (51.08 - 56.72) | Buy |
| Bollinger Bands (100): | (49.6 - 55.18) | Buy |
APLS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 33.6 | Sell |
| Chaikin Money Flow: | -1084788 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.37 - 40.01) | Sell |
| Bollinger Bands (100): | (36.55 - 42.35) | Sell |
PRIM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 55.97 | Buy |
| 20-day SMA: | 53.99 | Buy |
| 50-day SMA: | 53.54 | Buy |
| 200-day SMA: | 45.12 | Buy |
| 8-day EMA: | 56.33 | Buy |
| 20-day EMA: | 54.53 | Buy |
| 50-day EMA: | 53.32 | Buy |
| 200-day EMA: | 46.43 | Buy |
APLS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 36.19 | Sell |
| 20-day SMA: | 38.04 | Sell |
| 50-day SMA: | 37.88 | Sell |
| 200-day SMA: | 50 | Sell |
| 8-day EMA: | 35.96 | Sell |
| 20-day EMA: | 37.21 | Sell |
| 50-day EMA: | 38.25 | Sell |
| 200-day EMA: | 45.7 | Sell |
Primoris Services Earnings Growth & PRIM Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.19 per share, an increase next quarter of $0.24 per share, an increase this year of $0.58 per share, and an increase next year of $0.51 per share.
Apellis Pharmaceuticals Earnings Growth & APLS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.23 per share, an increase this year of $3.28 per share, and an increase next year of $1.34 per share.
Primoris Services Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Apellis Pharmaceuticals Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||